Concepedia

Raymond Alexanian

RA

175

Publications

23.5K

Citations

77

H-Index

1963

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Anderson Hospital

Lymphoma Research Foundation

The University of Texas System

Raymond Alexanian is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

1963–2014

175

Publications

175

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

International uniform response criteria for multiple myeloma

Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel et al. · Leukemia · 2006 · 2.6K citations

, , +3

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

Sundar Jagannath, Bart Barlogie, James R. Berenson et al. · British Journal of Haematology · 2004 · 739 citations · Full text

Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents

Bart Barlogie, Lon Smith, Raymond Alexanian · New England Journal of Medicine · 1984 · 654 citations

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

Paul G. Richardson, Hannah Briemberg, Sundar Jagannath et al. · Journal of Clinical Oncology · 2006 · 644 citations · Full text

Rows per page

1–5 of 175